Athenex

Athenex is focused on the development and commercialization of therapies for cancer and immunomodulatory diseases.

Launch date

2003

Employees

Market cap

Enterprise valuation

AUD403m (Public information from Aug 2023)

Buffalo New York (HQ)

http://athenex.com

https://twitter.com/athenexinc https://www.linkedin.com/company/athenex

Authorizing premium user...